文献速递基础与转化研究临床试验与 GCP

荧光胆碱激酶α抑制剂用于犬非小细胞肺癌术中分子成像

A fluorescent choline kinase alpha inhibitor for intraoperative molecular imaging during resection of canine NSCLC tumors.
PubMed 文献 · Sci Transl Med · 2026-10-21

研究开发近红外荧光胆碱激酶α靶向探针JAS239,在肺癌细胞中抑制磷酸胆碱生成并剂量依赖性降低活力,小鼠体内具良好药代动力学。犬临床试验中0.5毫克/千克剂量下肿瘤背景比5.0±0.6,识别隐匿病灶和近切缘,人肿瘤染色肿瘤背景比1.5±0.1。

要点

  • JAS239在犬肺癌术中成像肿瘤背景比5.0±0.6,可识别隐匿病灶和近切缘。
  • JAS239抑制肺癌细胞磷酸胆碱生成并剂量依赖性降低细胞活力。
  • 人离体肿瘤染色JAS239肿瘤背景比1.5±0.1,支持进一步人体评估。

核心结论

  • JAS239是安全有效的术中肺癌检测成像剂,值得进一步在肺癌患者中评估。

研究设计与样本

  • 开发近红外荧光ChoKα靶向探针JAS239,在肺癌细胞、小鼠和犬临床试验中评估。
  • 犬临床试验进行原发肺肿瘤原位和离体荧光成像,并行免疫组化检测ChoKα表达。
  • 人离体肿瘤染色评估JAS239定位。

主要发现

  • JAS239在肺癌细胞中抑制磷酸胆碱生成,剂量依赖性降低细胞活力,积聚于ChoKα活跃的细胞质。
  • JAS239在小鼠中具良好药代动力学和药效学,用于转移性肺病灶成像。
  • 犬临床试验中0.5毫克/千克剂量下肿瘤背景比5.0±0.6,对比方差比2.0±0.2。
  • 荧光成像发现原发肿瘤切除后的隐匿病灶和近切缘。
  • 犬肺肿瘤ChoKα免疫组化过表达与肿瘤荧光成比例。

临床怎么用

  • JAS239术中荧光成像可辅助识别肺癌肿瘤、边缘和局部转移。
  • 荧光成像可发现隐匿病灶和近切缘,提示需进一步探查。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Choline kinase α (ChoKα) is a biomarker of lung cancer, is overexpressed in 60% of human pulmonary malignancies, and is associated with an aggressive phenotype and poor clinical outcome. Patients with lung cancer who undergo surgery have a recurrence rate of 30 to 50%, indicating a potential need for better tumor detection modalities. A near-infrared fluorescent ChoKα-targeting imaging agent, JAS239 (λex, λem: 745, 775 nanometers), was developed for intraoperative identification of tumors, their margins, and local metastases. In lung cancer cells, JAS239 inhibited phosphocholine production, reduced viability in a dose-dependent manner, and accumulated in the cytoplasm where ChoKα is active. JAS239 had favorable pharmacokinetics and pharmacodynamics for imaging metastatic lung lesions in mice. In situ and ex vivo fluorescence imaging of primary lung tumors in a canine clinical trial showed distinct tumor identification and margin delineation with a tumor-to-background ratio of 5.0 ± 0.6 and a contrast-to-variance ratio of 2.0 ± 0.2 at 0.5 milligram/kilogram. Fluorescence imaging identified a clinically significant event where an occult lesion was found after primary tumor resection. Fluorescence imaging also identified a close surgical margin, which prompted further investigation. Immunohistochemistry for ChoKα showed overexpression in canine lung tumors proportional to tumor fluorescence. Ex vivo human tumor painting demonstrated preferential JAS239 localization with a tumor-to-background ratio of 1.5 ± 0.1 and a contrast-to-variance ratio of 0.9 ± 0.1. These studies establish JAS239 as a safe and effective imaging agent for intraoperative lung tumor detection, warranting further evaluation for human patients with lung cancer.

来源:Sci Transl Med,查看原文。版权归原作者所有。

引用

  1. Osharovich SA, Holt DE, Hart MC, et al. A fluorescent choline kinase alpha inhibitor for intraoperative molecular imaging during resection of canine NSCLC tumors. Sci Transl Med. 2026. PMID: 42905852. doi:10.1126/scitranslmed.aea4947

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。